• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞与慢性阻塞性肺疾病的发病机制

Macrophages and the pathogenesis of COPD.

作者信息

Tetley Teresa D

机构信息

National Heart & Lung Institute, Imperial College, London SW3 6LY, UK.

出版信息

Chest. 2002 May;121(5 Suppl):156S-159S. doi: 10.1378/chest.121.5_suppl.156s.

DOI:10.1378/chest.121.5_suppl.156s
PMID:12010845
Abstract

Macrophages are long-lived effector cells within the lung. They are reactive, responding to endogenous and exogenous stimuli, as well as proactive, producing mediators that modulate the behavior of surrounding cells. In addition, they play a critical role in the clearance of apoptotic neutrophils. Their role in COPD probably reflects a number of functional properties. However, if the link between increased proteinase burden and tissue destruction and injury in patients with COPD is correct, then macrophages must be very significant. Even though other cells, including epithelial cells and fibroblasts, have been shown to express higher matrix metalloproteinase (MMP) levels in lung tissue from subjects with COPD and emphysema, the numbers of resident cells do not appear to increase by the same factor as that of sequestered macrophages. The combination of a 5- to 10-fold increase in macrophage numbers, the up-regulation of MMPs, and their co-release with other classes of stored proteinases must be highly significant in terms of an increase in proteinase potential in the small airways and respiratory units. This may account for increased tissue destruction and inflammatory mediator activation leading to the pathology that occurs during COPD. Since only about 15% of smokers develop clinically significant disease, it seems likely, in smokers without COPD, that these processes either are strictly controlled or that lung repair mechanisms are more effective.

摘要

巨噬细胞是肺内的长寿效应细胞。它们具有反应性,能对内源性和外源性刺激作出反应,同时也具有主动性,能产生调节周围细胞行为的介质。此外,它们在清除凋亡中性粒细胞方面发挥着关键作用。它们在慢性阻塞性肺疾病(COPD)中的作用可能反映了多种功能特性。然而,如果蛋白酶负荷增加与COPD患者组织破坏和损伤之间的联系是正确的,那么巨噬细胞必定非常重要。尽管包括上皮细胞和成纤维细胞在内的其他细胞已被证明在COPD和肺气肿患者的肺组织中表达更高水平的基质金属蛋白酶(MMP),但驻留细胞的数量似乎不会像隔离的巨噬细胞那样以相同的倍数增加。巨噬细胞数量增加5至10倍、MMP上调以及它们与其他类别的储存蛋白酶共同释放,这三者的结合对于小气道和呼吸单位中蛋白酶潜力的增加必定具有高度重要性。这可能解释了导致COPD期间发生的病理变化的组织破坏增加和炎症介质激活。由于只有约15%的吸烟者会发展为具有临床意义的疾病,在没有COPD的吸烟者中,这些过程似乎要么受到严格控制,要么肺修复机制更有效。

相似文献

1
Macrophages and the pathogenesis of COPD.巨噬细胞与慢性阻塞性肺疾病的发病机制
Chest. 2002 May;121(5 Suppl):156S-159S. doi: 10.1378/chest.121.5_suppl.156s.
2
Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.慢性阻塞性肺疾病的发病机制。第一部分。蛋白酶-抗蛋白酶失衡在肺气肿中的作用。
Int J Tuberc Lung Dis. 2008 Apr;12(4):361-7.
3
Inflammatory cells and chronic obstructive pulmonary disease.炎症细胞与慢性阻塞性肺疾病
Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):607-18. doi: 10.2174/156801005774912824.
4
Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation.COPD 患者间质巨噬细胞中白细胞免疫球蛋白样受体 B4 的上调;其对肺气肿形成的可能保护作用。
Respir Res. 2021 Aug 23;22(1):232. doi: 10.1186/s12931-021-01828-3.
5
Inflammation of the airways and lung parenchyma in COPD: role of T cells.慢性阻塞性肺疾病中气道和肺实质的炎症:T细胞的作用。
Chest. 2002 May;121(5 Suppl):160S-165S. doi: 10.1378/chest.121.5_suppl.160s.
6
Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.鉴定慢性阻塞性肺疾病患者中糖皮质激素不敏感的肺巨噬细胞表型。
J Allergy Clin Immunol. 2014 Jan;133(1):207-16.e1-11. doi: 10.1016/j.jaci.2013.08.044. Epub 2013 Oct 28.
7
Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.嗜碱性粒细胞通过 IL-4 介导的 MMP-12 产生巨噬细胞引发 COPD 小鼠模型的肺气肿发展。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13057-13062. doi: 10.1073/pnas.1813927115. Epub 2018 Dec 3.
8
Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者肺泡巨噬细胞释放基质金属蛋白酶-9及金属蛋白酶组织抑制因子-1的情况与活性
Am J Respir Cell Mol Biol. 2002 May;26(5):602-9. doi: 10.1165/ajrcmb.26.5.4685.
9
New concepts in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的新概念
Annu Rev Med. 2003;54:113-29. doi: 10.1146/annurev.med.54.101601.152209. Epub 2001 Dec 3.
10
Zinc and zinc transporters in macrophages and their roles in efferocytosis in COPD.巨噬细胞中的锌及锌转运体及其在慢性阻塞性肺疾病(COPD)吞噬作用中的作用
PLoS One. 2014 Oct 28;9(10):e110056. doi: 10.1371/journal.pone.0110056. eCollection 2014.

引用本文的文献

1
Outer membrane vesicles in gram-negative bacteria and its correlation with pathogenesis.革兰氏阴性菌中的外膜囊泡及其与发病机制的相关性。
Front Immunol. 2025 Apr 1;16:1541636. doi: 10.3389/fimmu.2025.1541636. eCollection 2025.
2
Identification of benzo(a)pyrene-related toxicological targets and their role in chronic obstructive pulmonary disease pathogenesis: a comprehensive bioinformatics and machine learning approach.苯并(a)芘相关毒理学靶点的鉴定及其在慢性阻塞性肺疾病发病机制中的作用:一种综合生物信息学和机器学习方法
BMC Pharmacol Toxicol. 2025 Feb 17;26(1):33. doi: 10.1186/s40360-025-00842-1.
3
Prognostic value of composite inflammatory markers in patients with chronic obstructive pulmonary disease: A retrospective cohort study based on the MIMIC-IV database.
复合炎症标志物在慢性阻塞性肺疾病患者中的预后价值:一项基于MIMIC-IV数据库的回顾性队列研究。
PLoS One. 2025 Jan 24;20(1):e0316390. doi: 10.1371/journal.pone.0316390. eCollection 2025.
4
MAP2K1 dampens cigarette smoke-induced inflammation via suppression of type I interferon pathway activation.MAP2K1 通过抑制 I 型干扰素通路的激活来抑制香烟烟雾诱导的炎症。
Am J Physiol Lung Cell Mol Physiol. 2024 Nov 1;327(5):L740-L748. doi: 10.1152/ajplung.00080.2024. Epub 2024 Sep 24.
5
Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD).基于纳米结构的药物递送在缓解慢性阻塞性肺疾病(COPD)中的最新趋势与应用
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018289883240226113353.
6
The Activation of M1 Macrophages is Associated with the JNK-m6A-p38 Axis in Chronic Obstructive Pulmonary Disease.M1 巨噬细胞的激活与慢性阻塞性肺疾病中的 JNK-m6A-p38 轴相关。
Int J Chron Obstruct Pulmon Dis. 2023 Oct 6;18:2195-2206. doi: 10.2147/COPD.S420471. eCollection 2023.
7
Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P/HDAC1 signaling.鞘氨醇-1-磷酸/组蛋白去乙酰化酶1信号通路介导的巨噬细胞极化参与慢性阻塞性肺疾病的炎症反应。
Am J Cancer Res. 2023 Sep 15;13(9):4478-4489. eCollection 2023.
8
Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study.系统免疫炎症指数与慢性阻塞性肺疾病的相关性:一项基于人群的研究。
BMC Pulm Med. 2023 Aug 10;23(1):295. doi: 10.1186/s12890-023-02583-5.
9
Bulb of Thunb Extract Fermented with Reduces Inflammation in a Chronic Obstructive Pulmonary Disease Model.大蒜素发酵液对慢性阻塞性肺疾病模型的抗炎作用
J Microbiol Biotechnol. 2023 May 28;33(5):634-643. doi: 10.4014/jmb.2301.01022. Epub 2023 Feb 17.
10
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道微生物组-免疫相互作用。
Front Immunol. 2023 Jan 17;13:1085551. doi: 10.3389/fimmu.2022.1085551. eCollection 2022.